Kidney Contenders®

1.2K posts

Kidney Contenders® banner
Kidney Contenders®

Kidney Contenders®

@KidneyContender

We learn. We evolve. Our view is the kidney, but we contend for overall well-being. #healthwellness https://t.co/0vY8bM77zQ

Austin, TX Sumali Şubat 2021
47 Sinusundan130 Mga Tagasunod
Naka-pin na Tweet
Kidney Contenders®
Kidney Contenders®@KidneyContender·
Join our early‑supporter test on Android 📱✨ Help us build tools that empower kidney patients 💪🧡 Tap the link to become a tester 🔗⬆️ play.google.com/apps/testing/a…
English
0
1
2
167
Kidney Contenders®
Kidney Contenders®@KidneyContender·
@JACCJournals Repurposing established therapies is a smart strategy in cardio‑oncology. Early data on dantrolene’s role in DIC prevention is encouraging, but larger studies will be key to understanding real‑world impact.
English
0
0
0
14
Kidney Contenders®
Kidney Contenders®@KidneyContender·
@JAMACardio Feasibility matters, but outcomes still drive the conversation. Tailored meals support patients, yet this trial shows they’re not enough on their own to reduce HF events. Nutrition helps, but comprehensive management remains essential.
English
0
0
1
6
JAMA Cardiology
JAMA Cardiology@JAMACardio·
Food supplementation with medically tailored meals or fresh produce was feasible and well accepted in patients with #HeartFailure but did not reduce hospitalizations or emergency visits compared to usual care. ja.ma/4cnNQes
JAMA Cardiology tweet media
English
2
2
7
1.2K
Kidney Contenders®
Kidney Contenders®@KidneyContender·
@US_FDA Patients make decisions based on the evidence available. When results go unreported, the public record becomes incomplete and patients carry the risk. Full disclosure strengthens safety, trust, and scientific progress.
English
0
0
0
10
U.S. FDA
U.S. FDA@US_FDA·
Negative trial results often go unreported by companies and researchers, leaving significant gaps in the public record. Reporting results is not optional—it’s a legal and ethical obligation that helps protect patients and strengthen scientific integrity. fda.gov/news-events/pr…
U.S. FDA tweet media
English
11
20
41
5.7K
Kidney Contenders®
Kidney Contenders®@KidneyContender·
Early‑onset chronic disease is becoming the new baseline for too many younger adults. Conditions once seen in midlife are showing up decades earlier. The shift is quiet, measurable, and reshaping how prevention needs to work. Check out our full video on YouTube🩺
English
0
1
1
3
Kidney Contenders®
Kidney Contenders®@KidneyContender·
A staggering case. When fraud reaches this scale, it drains resources meant for real patients and erodes trust in care systems. Strong oversight and verification matter—especially in programs serving vulnerable communities. x.com/i/trending/204…
English
0
1
1
3
Kidney Contenders®
Kidney Contenders®@KidneyContender·
@WebMD The mind‑body link is real. Stress shifts immune signaling fast, and chronic worry keeps the system on high alert. Naming it is the first step toward breaking the cycle. Small resets matter more than people realize. 🌿
English
0
0
0
18
WebMD
WebMD@WebMD·
Stress and worry aren’t great germ fighters. Just having anxious thoughts can weaken your immune response in as little as 30 minutes. Constant stress takes an even bigger toll and makes it harder to fend off the flu, herpes, shingles, and other viruses. Talk to your doctor if you can’t shake your worry or if it gets in the way of normal life. wb.md/4c0ZGfO
WebMD tweet media
English
2
8
37
3.6K
Kidney Contenders®
Kidney Contenders®@KidneyContender·
@JAMACardio Important signal. In anterior MI, more therapy isn’t always better—low‑dose rivaroxaban added to DAPT didn’t reduce LV thrombus at 1 month and did increase minor bleeding. Highlights the need for sharper risk‑based selection. 🩺
English
0
0
0
39
JAMA Cardiology
JAMA Cardiology@JAMACardio·
Among patients with anterior myocardial infarction, adding low-dose rivaroxaban to dual antiplatelet therapy did not significantly reduce left ventricular thrombus formation at 1 month but increased minor bleeding. ja.ma/41rVvn3
JAMA Cardiology tweet media
English
1
22
72
5.3K
Pierre Elias, MD
Pierre Elias, MD@PierreEliasMD·
An 84-year-old woman with hypertension presented to the ED after a mechanical fall and found to have left femur fracture. Denies any cardiac symptoms. Vital signs normal, exam notable only for left-hip tenderness. What's the dx? Answer in 24 hrs @EricTopol @RobertHermanMD @djc795
Pierre Elias, MD tweet media
English
8
5
32
3.1K
Kidney Contenders®
Kidney Contenders®@KidneyContender·
@CircAHA @TorBiering @mvaduganathan @matslassen ARIC keeps showing how tightly CV, kidney, and metabolic pathways intersect. As CKM stages advance, remodeling and HF risk follow. It reinforces why upstream prevention and early risk identification matter long before symptoms appear.
English
0
0
0
16
Kidney Contenders®
Kidney Contenders®@KidneyContender·
@nutrition_facts Interesting comparison. Amla extracts show activity in lipid and platelet pathways, but head‑to‑head data with statins or antiplatelets need careful interpretation. Mechanisms differ, and clinical outcomes still rely on established therapies.
English
0
0
0
3
Michael Greger, M.D.
Michael Greger, M.D.@nutrition_facts·
Extracts of amla (Indian gooseberry) were pitted head-to-head against cholesterol-lowering statin drugs and the blood thinners aspirin and Plavix. see.nf/amla
Michael Greger, M.D. tweet media
English
3
24
95
3.9K
Kidney Contenders®
Kidney Contenders®@KidneyContender·
@JACCJournals Key reminder that TTVR success hinges on hemodynamics long before the device is deployed. Elevated filling pressures, PH, and renal dysfunction shift early risk, making selection and preprocedural optimization absolutely critical.
English
0
0
0
1
JACC Journals
JACC Journals@JACCJournals·
Acute hemodynamic instability is a life-threatening early complication after #TTVR. Higher left-sided filling pressures, pulmonary HTN & renal dysfunction increase risk, highlighting the need for careful selection & preprocedural optimization. jacc.org/doi/10.1016/j.… #JACCINT
JACC Journals tweet media
English
1
9
40
3.7K
Kidney Contenders®
Kidney Contenders®@KidneyContender·
@JAMACardio Important finding. Medically tailored meals improve experience and support patients, but this shows they’re not a substitute for comprehensive HF management. Feasibility matters, yet outcomes still depend on broader clinical and social factors.
English
0
0
0
1
JAMA Cardiology
JAMA Cardiology@JAMACardio·
Food supplementation with medically tailored meals or fresh produce was feasible and well accepted in patients with #HeartFailure but did not reduce hospitalizations or emergency visits compared to usual care. ja.ma/3Qn4cg0
JAMA Cardiology tweet media
English
3
3
18
6.2K
Kidney Contenders®
Kidney Contenders®@KidneyContender·
New video is up. Autism numbers are rising, but the real story is the signals behind the numbers. We break down the latest reporting from the Washington Post and explain why early support matters. ▶️Watch here: youtu.be/yyUHONfC8Sc?si…
YouTube video
YouTube
English
0
1
1
16
Kidney Contenders®
Kidney Contenders®@KidneyContender·
@oceana 🌿 A reminder that seagrass drives carbon capture, habitat stability, and long‑term ocean health. Vital work happening just below the surface.
English
0
1
1
7
Oceana
Oceana@oceana·
🌊🌿 Happy #WorldSeagrassDay! Seagrass might not seem like much at first glance, but it's a powerful force beneath the waves—storing carbon, providing shelter for marine life, and keeping our oceans healthy. Join Oceana in protecting vital ocean habitats today: oceana.ly/3RdHuVe
English
6
73
191
4.5K